Vectus Biosystems (ASX:VBS) Pretax Margin %: % (As of Dec. 2025)

What is Vectus Biosystems Pretax Margin %?

Vectus Biosystems ASX:VBS 18 Pretax Margin % is % as of Dec. 2025. GuruFocus rates ASX:VBS with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Vectus Biosystems ranks worse than 105708.14% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vectus Biosystems's Pre-Tax Income for the six months ended in Dec. 2025 was A$-0.73 Mil. Vectus Biosystems's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Vectus Biosystems's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Vectus Biosystems's Pretax Margin % or its related term are showing as below:

ASX:VBS's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Vectus Biosystems (ASX:VBS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Vectus Biosystems Pretax Margin % Related Terms

Vectus Biosystems Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Vectus Biosystems's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectus Biosystems Pretax Margin % Chart

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Pretax Margin %

Get a 7-Day Free Trial

0.00

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Pretax Margin %	Get a 7-Day Free Trial															-117,800.00	0.00	0.00	0.00	0.00

ASX:VBS vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Vectus Biosystems's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectus Biosystems Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Pretax Margin % falls into.

Save Embed

18GF Score

Vectus Biosystems Ltd ASX:VBS

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Vectus Biosystems Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Vectus Biosystems's Pretax Margin for the fiscal year that ended in Jun. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2025 )	/	Revenue (A: Jun. 2025 )
	=	-1.777	/	0
	=	%

Vectus Biosystems's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-0.732	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

Vectus Biosystems (ASX:VBS) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vectus Biosystems and its competitors. According to the industry distribution chart, Vectus Biosystems ranks #999999 out of 946 companies in the Biotechnology industry.

Is Vectus Biosystems' Pretax Margin % too high?

Vectus Biosystems' current Pretax Margin % is %. Based on the distribution chart, Vectus Biosystems ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vectus Biosystems has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.

How does Vectus Biosystems' Pretax Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Vectus Biosystems ranks #999999 out of 946 companies for Pretax Margin %. This places Vectus Biosystems in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vectus Biosystems and its competitors. Vectus Biosystems's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vectus Biosystems stock overvalued right now?

Vectus Biosystems (ASX:VBS) has a current Pretax Margin % of %. The current Pretax Margin % is %. Vectus Biosystems' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Vectus Biosystems (ASX:VBS), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vectus Biosystems Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:TRP ASX:NX1 ASX:BIT ASX:IXC ASX:CHM ASX:BGT ASX:ACR ASX:ANR ASX:1AD ASX:CMB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018

Website https://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.

18GF Score

Get the complete analysis for ASX:VBS

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.13

Price

View ASX:VBS Analysis

See Pretax Margin % data for all stocks →